NCT06233604View on ClinicalTrials.gov

Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Hip Arthroplasty

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

March 30, 2025

Study Completion Date

May 30, 2025

Conditions
Hip OsteoarthritisHip ArthropathyHip Pain Chronic
Interventions
DRUG

0.9%sodium chloride

unilateral administration of 20ml of 0,2% ropivacaine + 2ml 0.9% sodium chloride for the erector spine plane block

DRUG

Dexamethasone

unilateral administration of 20ml of 0,2% ropivacaine with 4mg Dexamethasone for the erector spine plane block

DRUG

Dexmedetomidine

unilateral administration of 20ml of 0,2% ropivacaine with 50ug Dexmedetomidine for the erector spine plane block

Trial Locations (1)

61-701

RECRUITING

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER